| 0 |
CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA |
1 |
0.2000 |
| 1 |
ADAMTS13 ACTIVITY INCREASED |
1 |
0.1250 |
| 2 |
UMBILICAL CORD THROMBOSIS |
1 |
0.0556 |
| 3 |
INHIBITING ANTIBODIES POSITIVE |
3 |
0.0526 |
| 4 |
GIANT CELL TUMOUR OF TENDON SHEATH |
1 |
0.0227 |
| 5 |
ADAMTS13 ACTIVITY DECREASED |
4 |
0.0154 |
| 6 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
3 |
0.0034 |
| 7 |
TONIC CONVULSION |
4 |
0.0028 |
| 8 |
DRUG LEVEL ABNORMAL |
1 |
0.0019 |
| 9 |
VULVOVAGINAL INJURY |
1 |
0.0018 |
| 10 |
BODY TEMPERATURE ABNORMAL |
3 |
0.0016 |
| 11 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
5 |
0.0014 |
| 12 |
OXYGEN SATURATION ABNORMAL |
4 |
0.0014 |
| 13 |
BREAST FEEDING |
1 |
0.0013 |
| 14 |
PLACENTAL INSUFFICIENCY |
1 |
0.0012 |
| 15 |
DYSCHROMATOPSIA |
1 |
0.0012 |
| 16 |
MATERNAL EXPOSURE DURING DELIVERY |
1 |
0.0010 |
| 17 |
HAEMOLYSIS |
6 |
0.0008 |
| 18 |
PREGNANCY |
13 |
0.0006 |
| 19 |
VEIN RUPTURE |
1 |
0.0006 |
| 20 |
MIOSIS |
4 |
0.0005 |
| 21 |
PANCREATITIS NECROTISING |
1 |
0.0004 |
| 22 |
METASTASES TO PERITONEUM |
1 |
0.0004 |
| 23 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 24 |
LARYNGOSPASM |
1 |
0.0004 |
| 25 |
MIGRAINE WITH AURA |
1 |
0.0004 |
| 26 |
LUNG ADENOCARCINOMA |
1 |
0.0003 |
| 27 |
MYDRIASIS |
4 |
0.0003 |
| 28 |
PLATELET COUNT INCREASED |
4 |
0.0003 |
| 29 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 30 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 31 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
4 |
0.0003 |
| 32 |
LOW BIRTH WEIGHT BABY |
2 |
0.0003 |
| 33 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 34 |
IRON DEFICIENCY |
1 |
0.0002 |
| 35 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 36 |
VAGINAL INFECTION |
1 |
0.0002 |
| 37 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 38 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 39 |
BLOOD PRESSURE ABNORMAL |
4 |
0.0002 |
| 40 |
POOR VENOUS ACCESS |
2 |
0.0002 |
| 41 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 42 |
VENTRICULAR SEPTAL DEFECT |
1 |
0.0002 |
| 43 |
MENISCUS INJURY |
1 |
0.0002 |
| 44 |
UNRESPONSIVE TO STIMULI |
4 |
0.0002 |
| 45 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 46 |
JAUNDICE |
4 |
0.0001 |
| 47 |
BLOOD BILIRUBIN INCREASED |
4 |
0.0001 |
| 48 |
PALLOR |
4 |
0.0001 |
| 49 |
FEELING COLD |
4 |
0.0001 |
| 50 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 51 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 52 |
CEREBRAL INFARCTION |
3 |
0.0001 |
| 53 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 54 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 55 |
OVARIAN CANCER |
1 |
0.0001 |
| 56 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 57 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 58 |
OVARIAN CYST |
1 |
0.0001 |
| 59 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 60 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 61 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 62 |
BREAST PAIN |
1 |
0.0001 |
| 63 |
PULMONARY OEDEMA |
4 |
0.0001 |
| 64 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 65 |
INSURANCE ISSUE |
1 |
0.0001 |
| 66 |
BRAIN FOG |
1 |
0.0001 |
| 67 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 68 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 69 |
NO ADVERSE EVENT |
10 |
0.0001 |
| 70 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 71 |
PHOTOPHOBIA |
1 |
0.0001 |
| 72 |
PROTEINURIA |
1 |
0.0001 |
| 73 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 74 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 75 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 76 |
CARDIAC ARREST |
4 |
0.0000 |
| 77 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 78 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 79 |
DEVICE MALFUNCTION |
3 |
0.0000 |
| 80 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 81 |
HAEMORRHAGE |
4 |
0.0000 |
| 82 |
PREMATURE BABY |
1 |
0.0000 |
| 83 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 84 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 85 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 86 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 87 |
VIRAL INFECTION |
1 |
0.0000 |
| 88 |
FUNGAL INFECTION |
1 |
0.0000 |
| 89 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 90 |
HAEMATURIA |
1 |
0.0000 |
| 91 |
UNDERDOSE |
2 |
0.0000 |
| 92 |
DYSARTHRIA |
1 |
0.0000 |
| 93 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 94 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 95 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 96 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 97 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 98 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 99 |
MIGRAINE |
2 |
0.0000 |
| 100 |
EYE IRRITATION |
1 |
0.0000 |
| 101 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0000 |
| 102 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 103 |
FEELING HOT |
1 |
0.0000 |
| 104 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 105 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 106 |
TACHYCARDIA |
1 |
0.0000 |
| 107 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 108 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 109 |
FLUSHING |
1 |
0.0000 |
| 110 |
HYPERTENSION |
2 |
0.0000 |
| 111 |
ASTHMA |
1 |
0.0000 |
| 112 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 113 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 114 |
VOMITING |
4 |
0.0000 |
| 115 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 116 |
HEADACHE |
5 |
0.0000 |
| 117 |
MALAISE |
3 |
0.0000 |
| 118 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 119 |
NAUSEA |
5 |
0.0000 |
| 120 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 121 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 122 |
SOMNOLENCE |
1 |
0.0000 |
| 123 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 124 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 125 |
WEIGHT INCREASED |
1 |
0.0000 |
| 126 |
DEPRESSION |
1 |
0.0000 |
| 127 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 128 |
COUGH |
1 |
0.0000 |
| 129 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 130 |
FALL |
1 |
0.0000 |
| 131 |
PYREXIA |
1 |
0.0000 |
| 132 |
ASTHENIA |
1 |
0.0000 |
| 133 |
PRURITUS |
1 |
0.0000 |
| 134 |
ARTHRALGIA |
1 |
0.0000 |
| 135 |
OFF LABEL USE |
2 |
0.0000 |
| 136 |
DIZZINESS |
1 |
0.0000 |
| 137 |
PAIN |
1 |
0.0000 |
| 138 |
DEATH |
1 |
0.0000 |